Results
912
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
912 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
500 | S$1.41 | -0.7% | -47.4% | S$4.8b | S$2.61 | PB0.8x | E72.5% | 0% | Capital Goods | ||
EOS | AU$1.71 | 2.1% | 51.3% | AU$307.8m | AU$1.83 | PS1.5x | E93.1% | n/a | Capital Goods | ||
2709 | CN¥14.47 | -3.9% | -59.6% | CN¥28.2b | CN¥20.35 | PE21.1x | E25.1% | 2.1% | Materials | ||
RAJESHEXPO | ₹295.60 | 0.1% | -43.8% | ₹87.0b | ₹600.00 | PE26x | E31.7% | 0% | Consumer Durables | ||
301093 | CN¥18.72 | -1.8% | -41.4% | CN¥2.4b | CN¥28.82 | PE25.2x | E33.9% | 3.2% | Healthcare | ||
A003230 | ₩544,000.00 | -7.8% | 209.1% | ₩4.2t | ₩712,000.00 | PE23.8x | E23.7% | 0.4% | Food, Beverage & Tobacco | ||
ORCL | US$134.26 | 4.7% | 14.5% | US$365.4b | US$148.92 | PE35.3x | E15.9% | 1.2% | Software | ||
NIL B | SEK 68.80 | 1.2% | 19.0% | SEK 784.5m | n/a | PE14.4x | E16.6% | 1.5% | Consumer Durables | ||
ELD | AU$9.08 | 0% | 29.5% | AU$1.4b | AU$8.83 | PE22.6x | E22.8% | 4.0% | Food, Beverage & Tobacco | ||
ASB | US$20.60 | 2.0% | 16.5% | US$3.0b | US$23.90 | PB0.8x | E35.2% | 4.3% | Banks | ||
LSS | €26.05 | 4.6% | -10.2% | €986.8m | €34.58 | PE30.9x | E29.3% | 1.4% | Software | ||
SFR | AU$8.22 | -1.1% | 35.9% | AU$3.8b | AU$9.43 | PS3.1x | E52.3% | 0% | Materials | ||
CTKB | US$5.35 | -4.8% | -38.6% | US$687.8m | US$9.13 | PS3.6x | E114.3% | n/a | Pharmaceuticals & Biotech | ||
SLEEP | SEK 40.40 | 0.7% | 52.5% | SEK 819.2m | SEK 55.00 | PE14.8x | E20.9% | 5.7% | Software | ||
5201 | JP¥4,660.00 | 2.5% | -3.5% | JP¥983.4b | JP¥5,695.56 | PB0.7x | E63.4% | 4.5% | Capital Goods | ||
AVBH | US$18.75 | 1.4% | -11.8% | US$147.8m | US$23.50 | PB0.9x | E22.3% | n/a | Banks | ||
LVR | S$0.85 | 0.6% | -80.0% | S$149.9m | S$2.30 | PB1.3x | E143.5% | n/a | Media | ||
BILL | US$48.00 | 9.2% | -53.0% | US$4.9b | US$76.05 | PS4.1x | E28.7% | n/a | Software | ||
6652 | JP¥2,664.00 | 5.0% | -11.9% | JP¥77.3b | JP¥3,075.00 | PE24.2x | E21.1% | 4.9% | Capital Goods | ||
BOW | US$26.89 | -0.3% | n/a | US$882.4m | US$29.60 | PE33.7x | E35.2% | n/a | Insurance | ||
OC | US$159.49 | 1.2% | 12.9% | US$13.5b | US$186.68 | PE13.2x | E16.6% | 1.5% | Capital Goods | ||
4495 | JP¥1,331.00 | 21.0% | 3.7% | JP¥6.4b | n/a | PE15.2x | E36.0% | 2.4% | Software | ||
GXI | €96.60 | 2.9% | -18.8% | €3.3b | €132.19 | PE28.9x | E22.2% | 1.3% | Pharmaceuticals & Biotech | ||
ALVGO | €3.26 | 8.7% | -20.3% | €19.9m | €4.40 | PS1.6x | E77.2% | n/a | Software |